Sandy Balkin

Sandy Balkin is SVP of Strategy & Analytics at Royalty Pharma. He is responsible for building and managing a cross-functional team charged with leveraging data to identify and support investment opportunities. Prior to joining Royalty Pharma, Sandy was managing director and leader of the Truist Securities’ Data Science and Engineering Research team developing capabilities in data science, machine learning and alternative data and integrating them into quantamental investment research. Over his career, he has built and led advanced business analytics functions at top pharmaceutical companies including Pfizer, Boehringer Ingelheim, and Sanofi.

Sandy has a PhD in business administration from Penn State University, an MA in statistics from Penn State University, as well as a BA in mathematics and economics and music from Lafayette College, where he graduated with honors. Sandy currently holds an adjunct faculty position at Columbia University and is on the leadership committee of the Mt. Sinai/Royalty Pharma Alliance on Health Equity Research.